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Measurements were performed with a gradient (in 5.5 min from 5% B to 100% B, back in 0.1 min to 0% B, total run time 9 min) at 40 °C with 0.7 mL/min. Solvent A consists of 99.9% water, and 0.1% TFA, solvent B of 99.9% acetonitrile, and 0.1% TFA.
Analytical LC-MS
Analytical LC-MS and determination of ESI-HRMS (Phenomenex Luna C18 column (3.0 µm, 100×2.0 mm)) was performed on an Agilent 6220 TOF-MS (Agilent Technologies) with a dual ESIsource operating with a spray voltage of 2.5 kV, 1200 HPLC system with autosampler, degasser, binary pump, column oven and diode array detector. Nitrogen was generated by a nitrogen generator NGM 11 and served as nebulizer and dry gas. External calibration was performed with ESI-L Tuning Mix (Agilent Technologies). Measurements were performed with a gradient (in 11 min from 0% B to 100% B, back in 0.5 min to 0% B, total run time 15 min) at 40 °C with 0.3 mL/min. Solvent A consists of 94.9% water, 5% acetonitrile, and 0.1% formic acid, solvent B of 94.9% acetonitrile, 5% water, and 0.1% formic acid.
MALDI-TOF-MS
MALDI-TOF-MS was conducted with an Ultraflex (Bruker Daltonik) operated in reflectron positive mode using an LTB nitrogen laser MNL200 (337 nm, 50 Hz, 1000 shots/spectrum, maximum resolution: 20000) using DHB (2,5-dihydroxybenzoic acid) or 4-chloro-α-cyanocinnamic acid (ClCCA) as a matrix. Samples were dissolved in mixtures of acetonitrile and water and calibration was conducted S3 with PEG 400-1200. FlexControl 3.0 and FlexAnalysis 3.4 (Bruker Daltonik) were used for recording and processing.
Preparative HPLC
Preparative HPLC was performed using a Merck-Hitachi LaChrom HPLC consisting of interface D-7000, pump L-7150, detector L-7420 and a Hypersil Gold C18 column (1.9 µm, 250×21.2 mm) at a flow rate of 10 mL/min. Solvent A consist of 94.9% water, 5% acetonitrile, and 0.1% TFA, solvent B of 94.9% acetonitrile, 5% water, and 0.1% TFA. 
UV/Vis absorbance spectroscopy
UV-visible spectroscopy was performed on an Agilent 8453 system equipped with a combination of deuterium-discharge lamp and a tungsten lamp to cover the UV/Vis wavelength range from 190-S4 1100 nm. As detector a photodiode array is used and a tempered 8-position sample holder with temperature control using PT-104A resistance thermometer. Measurements were done at 20 °C.
Fluorescence spectroscopy
Acquisition of fluorescence excitation and emission spectra were performed on a Jasco FP-8300 fluorescence spectrometer equipped with a peltier thermostated 4-position automatic cell changer (10 mm rectangular cells) at 20 °C using a Xe light source.
Enzymatic Bromination of Tryptophan
Halogenation on a preparative scale was performed using our previously established ADH-PrnF-RebH-combiCLEA method. [1] Briefly, cells overexpressing halogenase RebH (Uniprot ID: Q8HKZ8) from 1.5 L expression culture were applied for 1 L of reaction buffer consisting of 1 mM D-Trp, 30 mM NaBr, 15 mM Na2HPO4, 100 µM NAD + , 1 µM FADH and 5 mL i-PrOH in water. When the conversion stops, solvent is removed under reduced pressure and the residue is first desalted with a manual C18 reversedphase column (25 g, 400-220 mesh) and then purified by RP-HPLC. Fmoc-protection was performed according to our previously published procedure. [1] 
Peptide Synthesis
Linear peptides were synthesized according to Fmoc/ t Bu chemistry in a plastic syringe with a polypropylene porous disk at rt on an automated shaker. Peptides were synthesized on 2-chlorotrityl chloride (CTC, 1 mmol/g) resin manually. Fmoc deprotection was performed by treating the resin with 20% piperidine in DMF for 2×20 min. Sequential washing steps were conducted with DMF or NMP (5×). Coupling of standard Fmoc-protected amino acids (5 equiv) was accomplished with O- reduced pressure and the crude was applied for cross-coupling without purification. reduced pressure and the crude was purified by RP-HPLC. [1] Compound 
Late-stage Modification by SMC

Attachment of PEG-linker
The crude peptide obtained after SMC and Boc deprotection (1 equiv) and MeO-PEG-NHS (1.5 equiv)
were dissolved in dry DMF (4-8 mL) and to this DIPEA (3 equiv) was added. The solution was stirred in the dark for 1.5-2 d. Reaction control was performed with a combination of LC-MS and MALDI-TOF-MS. The solvent was removed under reduced pressure and the crude was purified by RP-HPLC.
Subsequently, Pbf-protecting group was cleaved with a mixture of TFA/TIS/H2O (3-6 mL, 95:2.5:2.5 v/v/v) for 2 h. The solvent was reduced in vacuo and precipitated with cold diethylether (50-100 mL).
The precipitate was cooled for further 20 min at 4 °C and centrifuged (2900×g, 15 min, 4 °C). The supernatant was decanted and the residue dissolved in water/acetonitrile and lyophilized.
Compound 2. Compound 2 was obtained as a colorless solid (75.9 mg, 12 µmol, 75%). Mass was detected in a range from 5000-7000 m/z due to PEG (average MW: 5900 g/mol).
Compound 4. Compound 4 was obtained as a colorless solid (109.9 mg, 9.6 µmol, 40%). Mass was detected in a range from 10000-13000 m/z due to PEG (average MW: 11500 g/mol).
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Integrin Binding Assay
An ELISA-like assay using isolated integrins was performed to determine activity. Cilengitide (αvβ3: with the inflection point describing the IC50 value (sigmoidal fitting: DoseResp). Each compound was tested in triplicates and referenced to the internal standard. [2] penicillin/streptomycin at 37 °C and 5.3% CO2. Cells were screened on a regular basis for contamination with mycoplasma.
Flow Cytometry Analysis. M21 and M21L cells were detached using accutase (4 mL) for 10 min at 37 °C. After centrifugation (800×g, 6 min, 24 °C) cells were resuspended in medium and 2×10 6 cells were seeded out in Eppendorf tubes. Cells were spun down and resuspended with 250 µL of peptide (30 µM) in medium without FCS. After incubation for approx. 0, 10 and 30 min at 37 °C and 500 rpm including a delay of ~30 sec due to handling, cells were spun down in a precooled centrifuge (800×g, 6 min, 4 °C) and washed with cold PBS (1×). For flow cytometry measurements cells were resuspended in RPMI without FCS (500 µL). Samples were measured with FCS. Acquisition of 10,000 events for each sample was performed using a Gallios flow cytometer (Beckman Coulter) equipped with a 405 nm laser. Data were analysed using FlowJo software v.10. Negative controls were only incubated with medium. Experiments were conducted as biological duplicates and technical triplicates.
Flow cytometry analysis with primary antibody. Similar to previous experiments, M21 cells were detached and seeded out into Eppendorf tubes (2×10 6 ). Cells were incubated with mouse anti-human CD51/CD61 antibody at 1 µg/mL in serum-free medium for 15 min on ice. Cells were washed with cold PBS buffer (1×) and incubated with peptide 1 and 2 (30 µM) in serum-free medium for 0 and 10 min at 37 °C. Finally, peptides were washed with PBS buffer (1×) and resuspend in medium for flow cytometry. Negative controls were only incubated with medium.
Temperature dependent flow cytometry. M21 cells were seeded into two 24-well plates (2×10 5 ) and grown overnight. Cells were washed either with cold or warm PBS buffer (2×) and incubated with peptide (30 µM) for 0 and 10 min at 37 °C or 4 °C. After washing with PBS buffer (4×) cells were detached using accutase and diluted with medium prior to flow cytometry.
Live cell fluorescence microscopy. 2×10 4 (M21) and 4×10 4 (M21L) cells were seeded out in an 8-well μ-slide (Nunc, LabTek) in medium (300 μL) and incubated overnight. Microscopy was performed using an incubation chamber at 37 °C to maintain cell culture conditions. Cells were stained with LysoTracker Peptide 4 S15
